OXYGENTA PHARMACEUTICAL
Back to Income Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹40 Cr | ₹31 Cr | ₹6,052,481 Cr | ₹52 Cr | ₹14 Cr |
What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹40 Cr |
| Mar2024 | ₹31 Cr |
| Mar2023 | ₹6,052,481 Cr |
| Mar2022 | ₹52 Cr |
| Mar2021 | ₹14 Cr |
How is Revenue of OXYGENTA PHARMACEUTICAL Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹40 Cr | 27.93 | |
| Mar2024 | ₹31 Cr | -100.00 | |
| Mar2023 | ₹6,052,481 Cr | 11,633,245.46 | |
| Mar2022 | ₹52 Cr | 279.32 | |
| Mar2021 | ₹14 Cr | - | |
Compare Revenue of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹225.8 Cr | -2.7% | 9% | -19.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,847.0 Cr | 6.8% | -1.5% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,745.0 Cr | 0% | -4.8% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,346.0 Cr | 1.7% | 4.1% | 20.5% | Stock Analytics | |
| CIPLA | ₹107,075.0 Cr | 0.1% | -12.8% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,507.0 Cr | 1.8% | -0.7% | 3.4% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -2.7% |
9% |
-19.6% |
| SENSEX | 1.5% |
-2.3% |
9.5% |
You may also like the below Video Courses